Current management of sacral chordoma.

Daryl R. Fourney, Ziya L. Gokaslan

Research output: Contribution to journalReview articlepeer-review

Abstract

Sacral chordomas are relatively rare, locally invasive, malignant neoplasms. Although metastasis is infrequent at presentation, the prognosis for patients with chordoma of the sacrum is reported to be poor and attributable in most cases to intralesional resection. The value of adjuvant treatment is uncertain, and resection remains the primary mode of treatment. Chordomas are difficult to excise completely, but recent improvements in imaging and surgical techniques have allowed surgeons to perform more frequently en bloc sacral resections with wide surgical margins. The technical challenges of such operations, and the functional costs for the patient (with respect to anorectal and urogenital dysfunction) are significantly increased when the tumor involves high sacral levels. The authors review the clinical presentation and natural history of sacral chordoma and discuss the current treatment techniques and outcomes.

Original languageEnglish (US)
Pages (from-to)E9
JournalNeurosurgical focus
Volume15
Issue number2
DOIs
StatePublished - Aug 15 2003

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Current management of sacral chordoma.'. Together they form a unique fingerprint.

Cite this